-transparent.png){kind=logo}
63 patients on long-term oral therapy with phenytoin sodium (sodium diphenylhydantoin) were screened for abnormalities of immunological function. They were compared with 92 controls and 28 patients with lymphoma. Depression of cellular or humoral immunity, or both, was found in a significant number of phenytoin-treated and lymphoma subjects. Phenytoin therapy was associated with low immunoglobulin A (21%), failure of antibody response to Salmonella typhi antigen (9%), absence of delayed hypersensitivity (D.H.S.) to three common skin-test antigens (22%), and depression of in-vitro lymphocyte transformation by phytohaemagglutinin (27%). Lymphoma patients manifested low IgM (22%), and inability to make antibody to S. typhi (11%) and to tetanus toxoid (21%). D.H.S. was absent in 36%; lymphocyte transformation was depressed in 17%. Abnormal lymphocyte transformation did not correlate with depression of cellular or humoral immunity in either group.
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
January 1976,
European neurology,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
February 1972,
Lancet (London, England),
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
January 1981,
Acta neurologica. Quaderni,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
February 1981,
Acta neurologica,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
January 1989,
Journal of child neurology,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
March 1964,
Epilepsia,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
February 1976,
The Medical letter on drugs and therapeutics,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
November 1975,
Journal of the American Pharmaceutical Association,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
September 1975,
Clinical chemistry,
T C Sorrell, and
I J Forbes, and
F R Burness, and
R H Rischbieth
April 1976,
Clinical chemistry,
